Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

FAK

Focal adhesion kinase (FAK), a non-receptor tyrosine kinase, is the first intracellular step in the signal transduction cascade initiated by the attachment of an integrin to the extracellular matrix at points known as focal adhesions. FAK has a key role in cellular migration and motility.

Ifebemtinib
T641671227948-82-4In house
Ifebemtinib (BI-853520) is an orally active and potent inhibitor of adhesion plaque kinase (FAK) (IC50=1 nM) with anti-tumour activity that inhibits globule formation and in situ tumour growth in malignant pleural mesotheliomas, and may be useful for the study of breast and ovarian cancer.
  • $165
In Stock
Size
QTY
TargetMol | Inhibitor Hot
PND-1186
T19501061353-68-1
PND-1186 (VS-4718) is a specific and reversible FAK inhibitor with an IC50 of 1.5 nM.
  • $30
In Stock
Size
QTY
TargetMol | Inhibitor Hot
Defactinib
T19961073154-85-4
Defactinib (VS-6063) is a second-generation inhibitor of FAK that inhibits FAK phosphorylation at the Tyr397 site. Defactinib has potential antitumor activity.
  • $31
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Ifebemtinib FA
T64167L In house
Ifebemtinib FA (BI-853520 FA) is an orally active and potent inhibitor of adhesion patch kinase (FAK) with anticancer and antiproliferative activity for the study of ovarian and lung cancer.
  • $163
In Stock
Size
QTY
PF-562271
T2465717907-75-0
PF-562271 is an effective ATP-competitive, reversible inhibitor of FAK(IC50=1.5 nM) and Pyk2 kinase(IC50=13 nM).
  • $54
In Stock
Size
QTY
TargetMol | Inhibitor Sale
TargetMol | Citations Cited
NAMI-A
T16266201653-76-1
NAMI-A, a ruthenium-based compound, selectively targets tumor metastasis by inhibiting cancer cell adhesion and migration.
  • $47
In Stock
Size
QTY
PF-573228
T2001869288-64-2
PF-573228 is an ATP-competitive FAK inhibitor. In a cell-free assay, the IC50 of FAK is 4 nM.
  • $45
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Corosolic acid
T33914547-24-4
Corosolic acid (Colosic acid) contains anti-angiogenic activity that can suppress FAK signaling induced by angiopoietin-1. Corosolic acid exerts anticancer activities against HCC, colon, and colorectal Y cells, by inducing apoptosis and promoting the N-terminal phosphorylation and subsequent proteasomal degradation of β-catenin.
  • $39
In Stock
Size
QTY
SU6656
T6997330161-87-0
SU 6656 is a selective inhibitor of Src family kinases, with IC50 of 280 nM, 20 nM, 130 nM, and 170 nM for Src, Yes, Lyn, and Fyn, respectively.
  • $34
In Stock
Size
QTY
TargetMol | Inhibitor Sale
CEP-37440
T26551391712-60-9
CEP-37440 is an effective and specific Dual FAK ALK inhibitor with IC50s of 120 nM(ALK cellular in 75% human plasma) and 2.3 nM (FAK).
  • $31
In Stock
Size
QTY
Y15
T71194506-66-5
Y15 (1,2,4,5-Benzenetetramine tetrahydrochlor) is a potent and specificsmall-molecule FAK scaffolding inhibitor that inhibits its autophosphorylation activity, blocks tumor growth.
  • $43
In Stock
Size
QTY
TargetMol | Inhibitor Hot
TargetMol | Citations Cited
Masitinib
T2609790299-79-5
Masitinib (AB1010) is a tyrosine-kinase inhibitor used in the treatment of mast cell tumors in animals, specifically dogs. Since its introduction in November 2008 it has been distributed under the commercial name Masivet. It has been available in Europe since the second part of 2009. In the USA it is distributed under the name Kinavet and has been available for veterinaries since 2011.
  • $31
In Stock
Size
QTY
Inulicin
TQ016933627-41-7
Inulicin (1-O-Acetylbritannilactone), an active compound isolated from Inula Britannica L, inhibits VEGF-mediated activation of Src and FAK.
    Inquiry
    Conteltinib
    T149971384860-29-0In house
    Conteltinib (CT-707) is an enzyme inhibitor with antitumor activity targeting FAK, ALK, and Pyk2.Conteltinib exhibits significant inhibition of FAK, overcomes hypoxia-mediated sorafenib resistance in hepatocellular carcinoma through inhibition of YAP signaling, and can be used in advanced ALK-positive non-small-cell lung cancer and lymphoma.
    • $100
    In Stock
    Size
    QTY
    GSK2256098
    T22811224887-10-8
    GSK2256098 (GTPL7939) is a small molecule FAK kinase inhibitor.
    • $39
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    TargetMol | Citations Cited
    ALK inhibitor 2
    T3041761438-38-4
    ALK inhibitor 2 is a new-type and selective inhibitor for the ALK kinase.
    • $118
    In Stock
    Size
    QTY
    FAK activator 1
    T776651211825-25-0In house
    ZINC40099027 is a specific adhesion plaque kinase (FAK) activator that promotes gastric mucosal repair in persistent aspirin-associated gastric injury through activation of adhesion plaque kinase, activates human adhesion plaque kinase by accelerating the enzyme activity of the structural domain of FAK kinase, activates cytosolic FAK, and promotes intestinal epithelial wound closure.
    • $93 TargetMol
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Hot
    Nitidine chloride
    T5S076113063-04-2
    1. Nitidine chloride has inhibitory effects on various tumors, such as renal cancer , breast cancer. 2. Nitidine chloride inhibits the proliferation of SMMC-7721 cells in vitro in a time- and dose-dependent manner and identifies efficacy in vivo in a mouse model of HCC.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    GSK215
    T678432743427-26-9
    GSK215 is a potent and selective PROTAC focal adhesion kinase (FAK) degrader (pDC50= 8.4), designed using the FAK inhibitor VS-4718 and a binder for the VHL E3 ligase, capable of inducing rapid and prolonged FAK degradation.
    • $127
    In Stock
    Size
    QTY
    AZ7550
    T135641421373-99-0
    AZ7550, an active metabolite of AZD9291, inhibits the activity of IGF1R (IC50: 1.6 μM).
    • $133
    In Stock
    Size
    QTY
    Batatasin III
    TN143356684-87-8
    Batatasin III inhibits cancer migration and invasion by suppressing epithelial to mesenchymal transition and FAK-AKT signals and possesses anti-cancer activities. Batatasin III has a long-term inhibitory effect on whole-plant growth and shows germination
    • $107
    In Stock
    Size
    QTY
    NVP-TAE 226
    T1918761437-28-9
    NVP-TAE 226 (TAE226) is a potent FAK inhibitor (IC50: 5.5 nM), exhibiting even greater efficacy against Pyk2 (IC50: 3.5 nM), and is 10- to 100-fold less effective against IGF-1R, InsR, c-Met, and ALK.
    • $41
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    TargetMol | Citations Cited
    PF-431396
    T2314717906-29-1
    PF-431396 is a dual PYK2/FAK inhibitor (IC50: 11/2 nM).
    • $50
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    TargetMol | Citations Cited
    BMS-536924
    T6419468740-43-4
    BMS-536924 (BMS 536924) is an ATP-competitive IGF-1R IR inhibitor with IC50 of 100 nM 73 nM, modest activity for Mek, Fak, and Lck with very little activity for Akt1, MAPK1 2.
    • $33
    In Stock
    Size
    QTY
    PF-562271 hydrochloride
    T21768939791-41-0
    PF-562271 hydrochloride (PF-562271 HCl) is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM in cell-free assays, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.
    • $71
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    (R)-Fangchinoline
    T280933889-68-8
    (R)-Fangchinoline ((+)-Thalrugosine) is extracted from Stephania tetrandra S. Moore.
    • $30
    In Stock
    Size
    QTY
    AMP-945
    T95761393653-34-3
    AMP-945 is a proprietary focal adhesion kinase (FAK) inhibitor.
    • $98
    In Stock
    Size
    QTY
    Masitinib mesylate
    T85441048007-93-7
    Masitinib mesylate (AB-1010 mesylate) is a selective, orally bioavailable c-Kit inhibitor with an IC50 of 200 nM for human recombinant c-Kit, and IC50 values of 540 800 nM and 510 nM for PDGFRα β and LynB, respectively.
    • $30
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    PF-562271 besylate
    T6177939791-38-5
    PF-562271 besylate (PF-00562271 Besylate) is a potent, ATP-competitive, reversible inhibitor of FAK with IC50 of 1.5 nM, ~10-fold less potent for Pyk2 than FAK and >100-fold selectivity against other protein kinases, except for some CDKs.
    • $32
    In Stock
    Size
    QTY
    TargetMol | Inhibitor Sale
    Chloropyramine hydrochloride
    T02636170-42-9
    Chloropyramine hydrochloride (Alergosan) is a histamine receptor H1 antagonist.
    • $33
    In Stock
    Size
    QTY
    BI-4464
    T54801227948-02-8
    BI-4464, a highly selective ATP-competitive inhibitor of PTK2 FAK, exhibits an IC50 of 17 nM and serves as a PTK2 ligand for PROTAC (Proteolysis Targeting Chimera).
    • $52
    In Stock
    Size
    QTY
    PF-03814735
    T6936942487-16-3
    PF-03814735 is a novel, potent and reversible inhibitor of Aurora A B with IC50of 0.8 nM 5 nM, is less potent to Flt3, FAK, TrkA, and minimally active to Met and FGFR1. Phase 1.
      Inquiry
      Defactinib hydrochloride
      T150921073160-26-5
      Defactinib hydrochloride (PF 04554878 hydrochloride) is a novel inhibitor of FAK. Which inhibits FAK phosphorylation at the Tyr397 site in a time- and dose-dependent manner.
      • $43
      In Stock
      Size
      QTY
      Roslin 2 bromide
      T2473029574-21-8In house
      Roslin 2 bromide (Benzylhexamethylenetetramine bromide) is a p53 reactivator that disrupts the binding of FAK and p5, exhibiting anticancer effects.
      • $44
      In Stock
      Size
      QTY
      TargetMol | Inhibitor Sale
      Compound 1T-0219 (SC)
      T9545383147-92-0
      Compound 1T-0219 (SC) is a blocker of AKT1-FAK interaction reducing the stimulation of FAK phosphorylation in response to extracellular pressure in human SW620 colon cancer cells without affecting basal FAK phosphorylation.
      • $148
      In Stock
      Size
      QTY
      FAK-IN-7
      T997319948-85-7
      FAK-IN-7 has potential antiproliferative activity and is a FAK inhibitor.
      • $30
      In Stock
      Size
      QTY
      TargetMol | Inhibitor Sale
      ALK inhibitor 1
      T10285761436-81-1
      ALK inhibitor 1 is a selective ALK kinase inhibitor.
      • $48
      In Stock
      Size
      QTY
      TargetMol | Inhibitor Sale
      YH-306
      T246421373764-75-0
      YH-306 (TRV055 acetate ) is a modulator of the FAK signaling pathway that acts by suppressing colorectal tumor growth and metastasis.
      • $29
      In Stock
      Size
      QTY
      TargetMol | Inhibitor Sale
      FAK-IN-10
      T77718491839-65-7
      FAK-IN-10 is an inhibitor of FAK (IC50: 76.3 μM) and demonstrates antitumor activity in MCF-7 and A431 cell lines with IC50 values of 4.23 μM and 0.78 μM, respectively.
      • $58
      In Stock
      Size
      QTY
      FAK-IN-14
      T778112766666-22-0
      FAK-IN-14 is a highly effective focal adhesion kinase (FAK) inhibitor that induces apoptosis and cell cycle arrest. FAK-IN-14 has weak inhibitory effects on Akt, c-kit, MEK1 2 and mTOR, but has significant inhibitory effects on FAK, FGFR1 and Pyk2.
      • $44
      In Stock
      Size
      QTY
      FAK-IN-15
      T77812
      FAK-IN-15 is a highly potent focal adhesion kinase (FAK) inhibitor with antitumor activity.
      • $195
      In Stock
      Size
      QTY
      5α-Hydroxycostic acid
      TN3139132185-83-2
      5alpha-Hydroxycostic acid possesses anti-angiogenic ability by interfering the VEGF- and Ang2-related pathways, and it may be a good drug candidate.
      • $162
      Backorder
      Size
      QTY
      TargetMol | Citations Cited
      2119738-71-3
      T46062119738-71-3
      Compound 2119738-71-3 interacts with the FAK receptor.
      • $72
      Backorder
      Size
      QTY
      Excisanin A
      TN404678536-37-5
      ExcisaninA may be a potent inhibitor of AKT signaling pathway in tumor cells, it can inhibit invasion by suppressing MMP-2 and MMP-9 expression, it may be a potential anti-metastatic chemotherapeutic agent for the treatment of breast cancer. Excisanin A shows comparable inhibitory effects on the LPS-induced production of NO and PGE2, and activation of NF-kappaB without affecting cell viability.Excisanin A induces apoptosis in colon cancer cell line SW620 as determined by Annexin V staining, the cleavage of caspase-3 and the proteolytic degradation of poly (ADP-ribose) polymerase (PARP).
      • $980
      Backorder
      Size
      QTY
      FAK-IN-12
      T82420
      FAK-IN-12 (Compound 12S) is a selective FAK inhibitor with an IC50 of 47 nM, effectively suppressing proliferation of MGC-803, HCT-116, and KYSE30 cells with IC50 values of 0.24, 0.45, and 0.44 μM, respectively. Additionally, FAK-IN-12 promotes apoptosis and cellular senescence [1].
      • Inquiry Price
      Size
      QTY
      Si306
      T899641640012-88-9
      Si306, an Src inhibitor, exhibits antitumor activity by reducing the phosphorylation of focal adhesion kinase (FAK) and the expression of epidermal growth factor receptor (EGFR), thereby inhibiting the invasion of human glioblastoma (GBM).
      • Inquiry Price
      10-14 weeks
      Size
      QTY
      FAK-IN-11
      T79688
      FAK-IN-11 (Compound 4l), a FAK inhibitor, specifically targets the ATP binding pocket of FAK to prevent its phosphorylation. It exhibits cytotoxic effects on MDA-MB-231 cells, achieving an IC50 value of 13.73 μM, and induces non-apoptotic cell death in these cells [1].
      • Inquiry Price
      Size
      QTY
      FAK inhibitor 2
      T112602354405-14-2
      FAK inhibitor 2, antitumor and anti-angiogenesis activitiesis ,is a potent focal adhesion kinase (FAK) inhibitor with an IC50 of 0.07 nM .
      • $1,230
      6-8 weeks
      Size
      QTY